For the Inventor, By the Inventor

Enter assignee name

Rockville, MD, United States of America

Neuralstem, Inc.

USPTO Granted Patents = 23

% Expired Patents = 21.7

CIPO Patents = 2

EPO Patents = 6

Forward Citations = 59

Loading Chart...

Loading Chart...

17 inventors (with patents filed for the assignee):

Karl K Johe (21 out of 25 patents)

Thomas Hazel (8 out of 8 patents)

Judith Kelleher-Andersson (8 out of 8 patents)

4. Martin Marsala (4 out of 10 patents)

5. Osamu Kakinohana (4 out of 4 patents)

6. Ying Li (2 out of 27 patents)

7. Sripathy Venkatraman (2 out of 10 patents)

8. Bingidimi Itute Mobele (2 out of 9 patents)

9. Olga V Lapina (2 out of 4 patents)

10. Syed Mahmood (2 out of 2 patents)

11. Kellie Vercoe (2 out of 2 patents)

12. Jonathan Salsbury (2 out of 2 patents)

13. Mark McLaws (2 out of 4 patents)

14. Shinn-Zong Lin (1 out of 37 patents)

15. Woei-Cherng Shyu (1 out of 21 patents)

23 patents: Sort by Forward Citations

1. 10702555 - Stable neural stem cells comprising an exogenous polynucleotide coding for a growth factor and methods of use thereof (2020-07-07),

2. 10413534 - Amelioration of certain deficiencies due to stroke (2019-09-17),

3. 10322115 - Amelioration of neural deficits associated with diabetes (2019-06-18),

4. 10286010 - Methods of treating neurodegenerative conditions (2019-05-14),

5. 9750769 - Stable neural stem cells comprising an exogenous polynucleotide coding for a growth factor and methods of use thereof (2017-09-05),

6. 9744194 - Methods of treating ischemic spasticity (2017-08-29),

7. 9572807 - Protocols for treatment of major depressive disorder (MDD) (2017-02-21),

8. 9540611 - Methods for treating and/or reversing neurodegenerative diseases and/or disorders (2017-01-10),

9. 9481649 - Synthesis of a neurostimulative piperazine (2016-11-01),

10. 9465025 - Stable neural stem cell lines (2016-10-11),

11. 9278933 - Synthesis of a neurostimulative piperazine (2016-03-08),

12. 9220730 - Methods of treating ischemic spasticity (2015-12-29),

13. 8846914 - Compositions to effect neuronal growth (2014-09-30),

14. 8674098 - Compositions to effect neuronal growth (2014-03-18),

15. 8460651 - Methods of treating amyotrophic lateral sclerosis (ALS) (2013-06-11),

Neuralstem, Inc. is a biopharmaceutical company that focuses on the discovery, development, and commercialization of innovative treatments for neurological disorders. The company's proprietary stem cell technology platform enables the production of neural stem cells that can be used to create cell therapies targeting various diseases and injuries of the nervous system. Neuralstem aims to improve patients' lives through the advancement of regenerative medicine. For more information, please visit their website.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

Neuralstem, Inc.

23 Patents

#31 in Rockville, MD

#188 in Maryland

#14,401 in US

#27,619 in the World

Rockville, MD, United States of America

Neuralstem, Inc.

Forward Citations = 59

17 inventors:

Karl K Johe (21 out of 25 patents)

Thomas Hazel (8 out of 8 patents)

Judith Kelleher-Andersson (8 out of 8 patents)

4. Martin Marsala (4 out of 10 patents)

5. Osamu Kakinohana (4 out of 4 patents)

Please report any incorrect information to [email protected]

Loading…